The ciliary transition zone protein TMEM218 synergistically interacts with the NPHP module and its reduced dosage leads to a wide range of syndromic ciliopathies.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
21 07 2022
Historique:
received: 17 11 2021
revised: 18 01 2022
accepted: 19 01 2022
pubmed: 10 2 2022
medline: 27 7 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

Mutations in genes that lead to dysfunctional cilia can cause a broad spectrum of human disease phenotypes referred to as ciliopathies. Many ciliopathy-associated proteins are localized to the evolutionary conserved ciliary transition zone (TZ) subdomain. We identified biallelic missense and nonsense mutations in the gene encoding the transmembrane protein TMEM218 in unrelated patients with features related to Bardet-Biedl, Joubert and Meckel-Gruber syndrome (MKS) and characterized TMEM218 as a major component of the ciliary TZ module. Co-immunoprecipitation assays resulted in the physical interaction of TMEM218 with the MKS module member TMEM67/Meckelin that was significantly reduced by the TMEM218 missense change harboured by one of our patients. We could further validate its pathogenicity by functional in vivo analysis in zebrafish (Danio rerio) as a well-established vertebrate model for ciliopathies. Notably, ciliopathy-related phenotypes were most prominent by genetic interactions with the NPHP module component Nphp4. Conclusively, we describe TMEM218 as a new disease gene for patients with a wide spectrum of syndromic ciliopathy phenotypes and provide evidence for a synergistic interaction of TMEM218 and the NPHP module crucial for proper ciliary function.

Identifiants

pubmed: 35137054
pii: 6523245
doi: 10.1093/hmg/ddac027
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2295-2306

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Daniel Epting (D)

Department of Medicine IV, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.

Eva Decker (E)

Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.

Elisabeth Ott (E)

Department of Medicine IV, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.

Tobias Eisenberger (T)

Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.

Ingrid Bader (I)

Department of Clinical Genetics, University Hospital, Paracelsus Medical University, Salzburg, Austria.

Nadine Bachmann (N)

Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.

Carsten Bergmann (C)

Department of Medicine IV, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH